Scalper1 News
The recent pharma merger-and-acquisition frenzy has not only put the industry in the spotlight, it has also fueled healthy stock action among its leaders. Medical-Ethical Drugs, ranked No. 2 in Wednesday’s issue among the 197 industry groups tracked by IBD, has held in the top three for the past six weeks. It also houses many leaders that have staged breakouts or are working on bases. Ten of the group’s 42 stocks own a Composite Rating of 95 or Scalper1 News
Scalper1 News